

|


Neurotransmitters and other chemical signalling agents
| ATP (P2 purinoceptors) |
| Precursors: |
Normal cellular constituent; formed from ADP |
| Synthesising enzymes: |
Phosphorylases |
| Metabolising enzymes: |
Phosphatases |
| Metabolites: |
ADP, AMP, adenosine, inosine |
| Receptor subtypes |
Agonists |
Antagonists |
Second messenger |
| P2X |
beta-gamma-Me-ATP |
alpha-beta-Me-ATP
(desensitises)
suramin |
(+ve)g(cation) or
(up)gCa2+ |
| P2Y |
ADP-beta-F,
2-Me-S-ATP |
Reactive blue 2,
suramin |
PI, (+ve)gK |
| P2T (platelet) |
ADP |
Suramin, AMP |
(-ve) cAMP,
(+ve)g(cation) |
P2Z
(mast cell) |
ATP4- |
none |
? |
| P2U |
UTP |
none |
PI |
NB: (+ve) indicates increase; (-ve) indicates decrease.
Reviews
Kennedy, C. (1990) Arch. Int. Pharmacodyn. Ther. 303, 30-50.
Bradykinin
Angiotensin
II
Table of Contents
|